
Elisabeth Svanberg, who has previously worked at Janssen, BMS and Merck-Serano (now Merck), is joining the board of Leo Pharma.
Svanberg has been CMO at Kuste Biopharma since 2020, and also has board experience from Amolyt, Galapagos and Egetis Therapeutics.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app